Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

SC 13D/A [Amend] - General Statement of Acquisition of Beneficial Ownership

Form Type: SC 13D/A

Filing Date: 2023-11-21

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2023-11-20

View Filing

NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form Type: NT 10-Q

Filing Date: 2023-11-15

View Filing

D - Notice of Exempt Offering of Securities

Form Type: D

Filing Date: 2023-11-02

View Filing

SC 13D/A [Amend] - General Statement of Acquisition of Beneficial Ownership

Form Type: SC 13D/A

Filing Date: 2023-10-31

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2023-10-23

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2023-10-20

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2023-09-21

View Filing

SC 13D - General Statement of Acquisition of Beneficial Ownership

Form Type: SC 13D

Filing Date: 2023-09-11

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2023-08-10

View Filing